Resources

Selected
  • Systematic reviews (SYSVAC)
  • Pregnant women
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

270 results found

2025 ∙ Tinessia, A. Sabahelzain, M. M. King, C. Khalatbari-Soltani, S. Gunaratnam, P. Dadari, I. Lorenzo, J. C. Bhaumik, S. Sheel, M.

Systematic review of pro-equity strategies to improve vaccination among priority populations

  • All age groups
  • Pregnant women
  • Healthcare workers
  • Parents/caregivers
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Taye, B. A. Weldearegay, B. Y. Yirsaw, B. G. Belete, A. K.

Tetanus toxoid vaccination coverage and associated factors among pregnant women in East Africa: systematic review and meta-analysis

  • Africa
  • Pregnant women
  • Tetanus
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Lei, Z. J. Bai, M. X. Li, M. J. Jin, P. Ding, Y. B.

The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Clarke, M. McMillan, M. Giles, L. C. Riley, K. Andraweera, P. Richmond, P. C. Mathew, S. M. Marshall, H. S.

The impact of obesity on influenza Vaccine immunogenicity: A systematic review

  • All age groups
  • Pregnant women
  • Healthcare workers
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Zhang, X. Zhao, T. Xie, T. Zhang, S. Xu, Q. Cheng, Y. Wei, H. He, A. Liu, B. Lu, Q. B. Jiang, Y. Cui, F.

Tracking the progress of maternal pertussis vaccination coverage among upper-middle- and high-income countries and territories - a systematic review and modeling study

  • Pregnant women
  • Pertussis
  • Coverage
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.

Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines

  • Pregnant women
  • Newborn
  • Children
  • Adolescents
  • Chikungunya
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Jafari, Z. Kolb, B. E. Aiken, S. Wilson, S.

Updates on Auditory Outcomes of COVID-19 and Vaccine Side Effects: An Umbrella Review

  • All age groups
  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Adusei-Mensah, F. Olubamwo, O. Olaleye, S. Akter, L. Balogun, O. S. Moshoeshoe, R. J. Awoniyi, L. Olawuni, A. Kauhanen, J.

Updating the impact of mRNA COVID-19 vaccine exposure during pregnancy on obstetric and neonatal outcomes

  • Pregnant women
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Gabor, M. Schlosserova, A. Korchynska, O. O.

Vaccination in pregnancy: a systematic review of current evidence

  • Pregnant women
  • Influenza
  • Pertussis
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Khuu, E. Moussaoui, S. Vignier, N. Bonello, K. Archer, E.

Vaccine hesitancy among migrant populations in Europe: A mixed-methods systematic review

  • Europe
  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • Pregnant women
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
Loading...